Company intelligence / Profile preview

TeselaGen Biotechnology

San Francisco, California, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

TeselaGen provides a secure, AI-powered enterprise software platform that enables the automated design, assembly, optimization, and data management of biotechnological products, rapidly accelerating R&D processes for biopharma, ag-tech, and industrial biotech applications. No proprietary clinical drug pipeline; company is a platform technology provider rather than a therapeutic developer.

Modalities: ProteinEnzymeAntibodySmall moleculeSynthetic oligonucleotideGene therapymRNA-based drugsBiologic
Industry: Drug Discovery Services

Partnerships

Joint BioEnergy Institute (JBEI)NinthBioArzedaLanzatechProtein EvolutionMicrobyre

Beyond the preview

Go deeper on TeselaGen Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TeselaGen Biotechnology.

Explore the full profile